Stock Research for ECYT

ECYT

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ECYT Stock Chart & Research Data

The ECYT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ECYT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ECYT Due diligence Resources & Stock Charts

The ECYT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ECYT Detailed Price Forecast - CNN Money CNN View ECYT Detailed Summary - Google Finance
Yahoo View ECYT Detailed Summary - Yahoo! Finance Zacks View ECYT Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ECYT Trends & Analysis - Trade-Ideas Barrons View ECYT Major Holders - Barrons
NASDAQ View ECYT Call Transcripts - NASDAQ Seeking View ECYT Breaking News & Analysis - Seeking Alpha
Spotlight View ECYT Annual Report - CompanySpotlight.com OTC Report View ECYT OTC Short Report - OTCShortReport.com
TradeKing View ECYT Fundamentals - TradeKing Charts View ECYT SEC Filings - Bar Chart
WSJ View Historical Prices for ECYT - The WSJ Morningstar View Performance/Total Return for ECYT - Morningstar
MarketWatch View the Analyst Estimates for ECYT - MarketWatch CNBC View the Earnings History for ECYT - CNBC
StockMarketWatch View the ECYT Earnings - StockMarketWatch MacroAxis View ECYT Buy or Sell Recommendations - MacroAxis
Bullish View the ECYT Bullish Patterns - American Bulls Short Pains View ECYT Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ECYT Stock Mentions - StockTwits PennyStocks View ECYT Stock Mentions - PennyStockTweets
Twitter View ECYT Stock Mentions - Twitter Invest Hub View ECYT Investment Forum News - Investor Hub
Yahoo View ECYT Stock Mentions - Yahoo! Message Board Seeking Alpha View ECYT Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ECYT - SECform4.com Insider Cow View Insider Transactions for ECYT - Insider Cow
CNBC View ECYT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ECYT - OTC Markets
Yahoo View Insider Transactions for ECYT - Yahoo! Finance NASDAQ View Institutional Holdings for ECYT - NASDAQ


Stock Charts

FinViz View ECYT Stock Insight & Charts - FinViz.com StockCharts View ECYT Investment Charts - StockCharts.com
BarChart View ECYT Stock Overview & Charts - BarChart Trading View View ECYT User Generated Charts - Trading View




Latest Financial News for ECYT


Novartis CEO talks chasing cures over profitable treatments, says they will 'ultimately' be valued
Posted on Monday January 07, 2019

Jim Cramer and Novartis CEO Vas Narasimhan discuss how the drugmaker is refocusing its business to leverage new-age treatments and potential cures.


Endocyte Stockholders Approve Merger Agreement with Novartis AG
Posted on Thursday December 20, 2018

Endocyte, Inc. (ECYT) (“Endocyte”), a biopharmaceutical company developing targeted therapeutics for cancer treatment, today announced that at its Special Meeting of Stockholders held earlier today, Endocyte’s stockholders approved the adoption of the merger agreement pursuant to which Novartis AG will acquire Endocyte for $24 per share, or a total equity value of approximately $2.1 billion, in cash.


Why Arrowhead Pharmaceuticals Stock Rose Over 10% Yesterday
Posted on Thursday December 13, 2018

On December 12, Arrowhead Pharmaceuticals (ARWR) stock closed at $12.19, an ~11.53% rise from its previous day’s close of $13.62. Arrowhead Pharmaceuticals stock rose from $3.68 at the close of market on December 29, 2017, to reach $15.19 at the close of market on December 12, reflecting a ~313% year-to-date rise.


Do Hedge Funds Love Endocyte, Inc. (ECYT)?
Posted on Saturday December 08, 2018

Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the […]


Stock Market & Investing Books

Enter a stock symbol to view the stock details.